MACOM Technology Solutions
MTSI
194.91
-23.64
-10.82%
MACOM Technology Solutions
US · MTSI
#870 by market cap
Listed 1970
194.91
-23.64
-10.82%
Periodic snapshot; not a real-time feed.
· 2026-11-20 20:02
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 15.82, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +37.26% YoY
Margins
- Gross margin
- 58.03%
- Operating margin
- 23.01%
- Net margin
- 25.25%
Key ratios & quality
- PEG ratioi
- 0.84
- Altman Z-Scorei
- 15.82
PEG uses trailing P/E against the 3-year net income growth rate (54.12%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 499.71M | 530.04M | 606.92M | 675.17M | 648.41M | 729.58M | 967.26M | 1.33B |
| Gross profit | 220.71M | 270.17M | 341.86M | 406.18M | 385.80M | 393.77M | 529.00M | 770.40M |
| Selling & admin expenses | 153.29M | 124.31M | 122.01M | 125.28M | 129.85M | 137.95M | 154.88M | 179.10M |
| Research & development | 163.47M | 141.33M | 138.84M | 148.23M | 148.55M | 182.16M | 244.47M | 285.83M |
| Operating profit | -96.05M | 4.53M | 81.00M | 132.67M | 107.40M | 73.67M | 129.65M | 305.47M |
| Pretax profit | -423.15M | -41.56M | 42.95M | 243.12M | 115.16M | 91.53M | -29.03M | 389.89M |
| Tax | -39.36M | 4.52M | 4.97M | -196.84M | 23.58M | 14.67M | 25.19M | 54.64M |
| Net profit | -383.80M | -46.08M | 37.97M | 439.96M | 91.58M | 76.86M | -54.21M | 335.25M |
| Basic EPS | -6 | -1 | 1 | 6 | 1 | 1 | -1 | 4 |
| Diluted EPS | -5.84 | -0.69 | 0.54 | 6.18 | 1.28 | 1.04 | -0.73 | 4.31 |
| Line item | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 | 2026-10 |
|---|---|---|---|---|---|---|
| Revenue | 252.08M | 261.17M | 271.61M | 288.96M | 342.24M | 424.82M |
| Gross profit | 139.44M | 142.30M | 151.78M | 164.43M | 199.55M | 254.63M |
| Selling & admin expenses | 38.40M | 39.83M | 42.02M | 44.62M | 48.13M | 44.33M |
| Research & development | 63.38M | 62.88M | 66.46M | 68.98M | 74.31M | 76.08M |
| Operating profit | 37.66M | 39.60M | 43.30M | 50.83M | 77.12M | 134.22M |
| Pretax profit | 44.08M | 55.90M | 49.59M | 56.92M | 123.85M | 159.52M |
| Tax | 7.55M | 10.78M | 822.00K | 10.59M | 23.14M | 20.08M |
| Net profit | 36.53M | 45.12M | 48.77M | 46.33M | 100.71M | 139.45M |
| Basic EPS | 0 | 1 | 1 | 1 | 1 | 2 |
| Diluted EPS | 0.48 | 0.59 | 0.64 | 0.60 | 1.28 | 1.78 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 398.58M | 481.52M | 521.54M | 813.08M | 761.19M | 903.08M | 1.21B | 1.33B |
| Cash & ST investments | 176.75M | 333.15M | 344.90M | 586.53M | 514.53M | 581.89M | 785.98M | 792.41M |
| Inventory | 107.88M | 91.58M | 82.70M | 114.96M | 136.30M | 194.49M | 237.84M | 284.31M |
| Total assets | 1.11B | 1.15B | 1.13B | 1.57B | 1.55B | 1.76B | 2.10B | 2.32B |
| Total current liabilities | 74.84M | 94.95M | 93.04M | 97.21M | 83.53M | 108.18M | 325.12M | 522.89M |
| Short-term debt | 7.97M | 15.85M | 8.42M | 7.48M | 8.42M | 8.37M | 167.86M | 347.98M |
| Long-term debt | 655.27M | 652.17M | 492.10M | 565.92M | 447.13M | 448.28M | 339.63M | -- |
| Total liabilities | 791,678,000.00 | 846,282,000.00 | 662,409,000.00 | 729,069,000.00 | 605,644,000.00 | 629,297,000.00 | 776,265,000.00 | 626,184,000.00 |
| Total equity | 313.90M | 300.15M | 471.74M | 842.75M | 947.60M | 1.13B | 1.33B | 1.70B |
| Retained earnings | -791.77M | -839.73M | -801.75M | -354.29M | -262.71M | -185.85M | -240.06M | 95.19M |
| Line item | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 | 2026-10 |
|---|---|---|---|---|---|---|
| Total current assets | 1.13B | 1.21B | 1.21B | 1.13B | 1.17B | 1.33B |
| Cash & ST investments | 735.23M | 785.98M | 768.49M | 664.86M | 663.03M | 792.41M |
| Inventory | 215.39M | 237.84M | 238.91M | 252.20M | 281.52M | 284.31M |
| Total assets | 2.00B | 2.10B | 2.11B | 2.01B | 2.15B | 2.32B |
| Total current liabilities | 294.65M | 325.12M | 304.54M | 149.70M | 501.51M | 522.89M |
| Short-term debt | 161.54M | 167.86M | 161.21M | 6.97M | 347.51M | 347.98M |
| Long-term debt | 339.35M | 339.63M | 339.91M | 340.19M | -- | -- |
| Total liabilities | 739,921,000.00 | 776,265,000.00 | 752,410,000.00 | 596,820,000.00 | 605,994,000.00 | 626,184,000.00 |
| Total equity | 1.26B | 1.33B | 1.35B | 1.42B | 1.54B | 1.70B |
| Retained earnings | -285.18M | -240.06M | -191.29M | -144.96M | -44.25M | 95.19M |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 20.70M | 171.40M | 148.41M | 176.98M | 166.92M | 162.64M | 235.37M | 357.09M |
| Depreciation & amortization | 104.42M | 78.83M | 69.95M | 57.23M | 52.15M | 67.25M | 63.30M | 62.61M |
| Free cash flow | -17.26M | 153.82M | 130.46M | 150.47M | 142.22M | 137.01M | 153.20M | 221.38M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -4.14M | -6.71M | -23.44M | -36.00M | -32.62M | -14.22M | -43.14M | -56.94M |
| Ending cash balance | 75.52M | 129.44M | 156.54M | 119.95M | 173.95M | 146.81M | 112.14M | 112.01M |
| Line item | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 | 2026-10 |
|---|---|---|---|---|---|---|
| Operating cash flow | 60.39M | 69.64M | 42.93M | 78.66M | 79.96M | 155.54M |
| Depreciation & amortization | 14.85M | 17.65M | 15.38M | 15.64M | 15.65M | 15.94M |
| Free cash flow | 21.76M | 48.37M | 25.66M | 62.38M | -2.83M | 136.17M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -451.00K | -- | -- | -- | -1.36M |
| Ending cash balance | 125.47M | 112.14M | 119.65M | 98.52M | 89.60M | 112.01M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -78.12 | -15.01 | 9.84 | 66.94 | 10.23 | 7.41 | -4.42 | 22.17 |
| ROA %i | -29.66 | -4.09 | 3.33 | 32.52 | 5.86 | 4.65 | -2.81 | 15.15 |
| ROIC %i | -29.65 | -2.60 | 5.62 | 36.27 | 5.90 | 4.06 | -4.16 | 16.00 |
| 5-year avg ROE %i | -21.92 | -27.90 | -26.00 | -7.14 | -1.22 | 15.88 | 18.00 | 20.47 |
| EBIT margin %i | -77.52 | -2.68 | 10.47 | 36.65 | 19.67 | 13.25 | -2.43 | 29.84 |
| FCF / sales %i | -- | 29.02 | 21.50 | 22.29 | 21.93 | 19.22 | 15.84 | 16.68 |
| Current ratioi | 5.33 | 5.07 | 5.61 | 8.36 | 9.11 | 8.35 | 3.71 | 2.53 |
| Quick ratioi | 3.52 | 3.99 | 4.62 | 7.08 | 7.25 | 6.36 | 2.87 | 1.92 |
| Debt / assetsi | 62.66 | 60.80 | 46.60 | 38.20 | 31.37 | 27.78 | 25.58 | 16.26 |
| LT debt / equityi | 218.15 | 226.94 | 110.26 | 70.36 | 50.54 | 42.56 | 27.89 | 1.76 |
| Interest coveragei | -10.82 | -0.52 | 3.09 | 57.54 | 10.30 | 18.82 | -4.26 | 62.59 |
| Revenue CAGR (3Y) %i | -2.81 | -8.80 | 2.09 | 10.55 | 6.95 | 6.33 | 12.73 | 26.98 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | 26.50 | -- | 54.12 |
| FCF CAGR (3Y) %i | -- | 75.94 | -- | -- | -2.58 | 1.65 | 0.60 | 15.89 |
| Line item | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 | 2026-10 |
|---|---|---|---|---|---|---|
| ROE %i | -5.96 | -4.42 | 12.95 | 13.49 | 17.18 | 22.17 |
| ROA %i | -3.77 | -2.81 | 8.21 | 8.99 | 11.61 | 15.15 |
| ROIC %i | -5.19 | -4.16 | 7.90 | 8.80 | 11.90 | 16.00 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | -5.23 | -2.43 | 19.24 | 19.82 | 25.16 | 29.84 |
| FCF / sales %i | 18.94 | 15.84 | 12.11 | 14.73 | 11.48 | 16.68 |
| Current ratioi | 3.83 | 3.71 | 3.96 | 7.52 | 2.34 | 2.53 |
| Quick ratioi | 2.93 | 2.87 | 3.05 | 5.51 | 1.68 | 1.92 |
| Debt / assetsi | 26.53 | 25.58 | 25.24 | 18.73 | 17.58 | 16.26 |
| LT debt / equityi | 29.29 | 27.89 | 27.36 | 26.12 | 1.95 | 1.76 |
| Interest coveragei | -9.49 | -4.26 | 33.58 | 33.59 | 44.10 | 62.59 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Designs, develops, manufactures and markets semiconductors and modules100.00%
Quote time 2026-11-20 20:02:42 · For reference only, not investment advice and not tailored to your situation.
MACOM Technology Solutions discussion 0 comments